Development

Articles

This week, the US Pharmacopeial Convention and the Vietnamese Pharmacopoeia Commission signed a memorandum of understanding that will help ensure the safety of Vietnamese medicines.

USP Collaborates with Asian Authorities

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

Manufacturers Face New Risk-Management Requirements

Angie Drakulich was editorial director of Pharmaceutical Technology.

The regulators are doing it. But industry's fear of sharing information may leave them behind.

Can Industry Learn to Share?

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Is it good policy to pay for bad behavior?

The Good Society

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability.

Examining High-Potency API Manufacturing

Traditional Chinese Medicine is widely used, but questions persist regarding its regulatory status.

Inside USP: Traditional Chinese Medicines and Western Regulatory Paradigms

Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps down; more...

Company and People Notes: Synta and GSK End Agreement; WuXi Appoints US VP; More...

Generic-drug and specialty pharmaceutical manufacturer Watson Pharmaceuticals (Corona, CA) agreed to acquire the generic-drug company Arrow Group for $1.75 billion in cash and stock.

Watson to Acquire Arrow for $1.75 Billion

Following the 2008 launch of the European Fine Chemicals Group (EFCG) Voluntary Guidelines (VGs) to promote supply-chain security, the group has now announced the official launch of an assessment template that will allow fine chemicals customers and suppliers to assess and implement this new set of recommendations.

European Fine Chemicals Group Issues Assessment Tool to Promote Supply-Chain Security

Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI makes changes to its India management team; more...

Ingredients